Valuation: Teva Pharmaceutical Industries Limited

Market Cap 36.75B 32.12B 29.71B 27.26B 51.59B 3,541B 52.49B 354B 139B 1,729B 138B 135B 5,970B P/E 2026 *
39x
P/E 2027 * 17.2x
Enterprise Value 47.93B 41.9B 38.75B 35.56B 67.29B 4,619B 68.46B 462B 182B 2,255B 180B 176B 7,787B EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.62x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Limited

1 day+1.71%
1 week-3.08%
Current month-5.31%
1 month-2.52%
3 months+2.62%
6 months+1.01%
Current year+2.79%
1 week 31.28
Extreme 31.28
33.35
1 month 30.8
Extreme 30.8
35.47
Current year 27.93
Extreme 27.93
37.34
1 year 14.99
Extreme 14.99
37.34
3 years 7.95
Extreme 7.95
37.34
5 years 6.78
Extreme 6.7791
37.34
10 years 6.07
Extreme 6.07
55.79
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Date Insider Type Main position Quantity % Market Cap.
18/06/26 Sell

Chief Operating Officer

-9,989 0.0009%
11/06/26 Sell

Chief Financial Officer

-106,563 0.0091%
05/06/26 Fiscal year

Chairman

43,478 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
+1.68%-3.08%+100.37%+300.00% 36.75B
+1.08%-4.12%+47.73%+160.94% 1,031B
+1.50%-3.62%+51.55%+56.99% 595B
+3.46%+0.94%+32.36%+87.09% 431B
+0.42%-1.16%+29.43%+23.64% 326B
+1.03%-0.84%+29.58%+45.15% 277B
+0.49%-5.44%+21.00%+23.80% 263B
+1.59%+4.89%-22.56%-37.35% 224B
+2.81%+1.41%+23.32%+61.84% 193B
+3.04%+0.63%+23.52%+75.12% 164B
Average +1.66%-4.23%+33.63%+79.72% 354.1B
Weighted average by Cap. +1.52%-4.35%+35.06%+82.13%

Financials

2026 *2027 *
Net sales 16.65B 14.55B 13.46B 12.35B 23.37B 1,604B 23.78B 160B 63.04B 783B 62.51B 61.14B 2,704B 17.24B 15.07B 13.94B 12.79B 24.21B 1,661B 24.63B 166B 65.29B 811B 64.75B 63.33B 2,801B
Net income 1.54B 1.35B 1.25B 1.14B 2.17B 149B 2.2B 14.87B 5.84B 72.59B 5.79B 5.67B 251B 2.71B 2.37B 2.19B 2.01B 3.81B 261B 3.87B 26.14B 10.27B 128B 10.18B 9.96B 440B
Net Debt 11.18B 9.78B 9.04B 8.3B 15.7B 1,078B 15.97B 108B 42.35B 526B 42B 41.08B 1,817B 8.44B 7.37B 6.82B 6.26B 11.84B 813B 12.05B 81.32B 31.95B 397B 31.68B 30.98B 1,370B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
16/07/26 US$32.08 +1.65% 2,400,861
15/07/26 US$31.56 -0.82% 5,519,683
14/07/26 US$31.82 -1.12% 3,452,186
13/07/26 US$32.18 -2.34% 4,231,527
10/07/26 US$32.95 -0.45% 6,638,420
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
31.56USD
Average target price
40.90USD
Spread / Average Target
+29.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TEVA Stock